Study of Arrhythmia and ECG Abnormalities in Patients With COVID-19
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 196
- 试验地点
- 1
- 主要终点
- Proportion of ECGs abnormalities in patients SARS-CoV-2 infection
研究概览
简要总结
Cardiac involvement has been described in Severe Acute Respiratory Syndrome - Coronavirus-2 (SARS-CoV-2) infection. Although there are no approved drugs to prevent or treat SARS-CoV-2 infection at present time, several medications used have the potential to increase QT interval and eventually provoke torsades de pointe. The investigators therefore create a study that include all patients with SARS-CoV-2 infection having an electrocardiogram (ECG). The investigators evaluate the percentage of patients with ECG abnormalities, describe the abnormalities and evaluate the occurrence of syncope, ventricular arrhythmia and corrected QT (cQT) interval modification in patients receiving treatment.
详细描述
In patients with SARS-CoV-2 infection, the investigators analyze baseline ECG as well as follow-up ECG. Patients followed by Bordeaux University Hospital for COVID-19 can be included. ECG are digitized in the computerized patient file (DxCARE) for further analysis.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Other
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients over 18 years of both gender,
- •Followed by Bordeaux University Hospital for SARS-CoV-2 infection with a cardiac monitoring or ECG realized.
- •Non opposition expressed.
排除标准
- •Inability to understand the study
研究组 & 干预措施
SARS-CoV-2 infection
This group includes patients prospectively included during their follow-up at the Bordeaux University Hospital for COVID-19, as well as retrospectively included patients whose follow-up for COVID-19 has been completed.
干预措施: ECG data analysis (Diagnostic Test)
SARS-CoV-2 infection
This group includes patients prospectively included during their follow-up at the Bordeaux University Hospital for COVID-19, as well as retrospectively included patients whose follow-up for COVID-19 has been completed.
干预措施: Treatment data collect (Drug)
SARS-CoV-2 infection
This group includes patients prospectively included during their follow-up at the Bordeaux University Hospital for COVID-19, as well as retrospectively included patients whose follow-up for COVID-19 has been completed.
干预措施: Biological check-up data collect (Biological)
SARS-CoV-2 infection
This group includes patients prospectively included during their follow-up at the Bordeaux University Hospital for COVID-19, as well as retrospectively included patients whose follow-up for COVID-19 has been completed.
干预措施: Collection of clinical events of interest (Other)
结局指标
主要结局
Proportion of ECGs abnormalities in patients SARS-CoV-2 infection
时间窗: Day 0
Percentage of ECGs with abnormalities
次要结局
- Rate of cardiac death during treatment(Baseline and 1 month)
- Evolution of PR, QRS and cQT interval(Baseline and 1 month)
- Rate of syncope during treatment(Baseline and 1 month)
- Rate of arrhythmia during treatment(Baseline and 1 month)